GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates

Core Insights - GE HealthCare Technologies (GEHC) reported quarterly earnings of $1.45 per share, exceeding the Zacks Consensus Estimate of $1.26 per share, and up from $1.18 per share a year ago, representing an earnings surprise of 15.08% [1] - The company posted revenues of $5.32 billion for the quarter ended December 2024, slightly missing the Zacks Consensus Estimate by 0.25%, but up from $5.21 billion year-over-year [2] - GE HealthCare shares have increased approximately 9.9% since the beginning of the year, outperforming the S&P 500's gain of 2.9% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.98 on revenues of $4.75 billion, and for the current fiscal year, it is $4.65 on revenues of $20.38 billion [7] - The estimate revisions trend for GE HealthCare is currently unfavorable, leading to a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Medical - Products industry, to which GE HealthCare belongs, is currently ranked in the top 27% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - The performance of GE HealthCare's stock may be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and earnings estimate revisions [5]